285 related articles for article (PubMed ID: 9570679)
21. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of chronic haematological malignancies.
Ho AD
Baillieres Clin Haematol; 1991 Jan; 4(1):197-221. PubMed ID: 2039859
[TBL] [Abstract][Full Text] [Related]
23. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Dearden CE; Matutes E; Catovsky D
Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
[TBL] [Abstract][Full Text] [Related]
24. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
25. [Recurrent somatic mutation in hairy cell leukemia].
Sári E; Nagy Z; Demeter J
Orv Hetil; 2013 Jan; 154(4):123-7. PubMed ID: 23335721
[TBL] [Abstract][Full Text] [Related]
26. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
27. Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
Ho AD; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
Leukemia; 1992 Mar; 6(3):209-14. PubMed ID: 1564958
[TBL] [Abstract][Full Text] [Related]
28. Optimal treatment for untreated patients with hairy cell leukemia?
Troussard X; Flandrin G
J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
[No Abstract] [Full Text] [Related]
29. Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency.
Gozzetti A; Bacchiarri F; Raspadori D; Sicuranza A; Sammartano V; Bocchia M
Rev Recent Clin Trials; 2023; 18(4):300-303. PubMed ID: 37779396
[TBL] [Abstract][Full Text] [Related]
30. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.
Robak T; Robak P
Curr Pharm Des; 2012; 18(23):3373-88. PubMed ID: 22591387
[TBL] [Abstract][Full Text] [Related]
31. Hairy cell leukemia: a successful model for experimental therapeutics--pentostatin and new ideas.
Grever MR
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():25-8. PubMed ID: 21599604
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic leukemia and hairy-cell leukemia.
Cheson BD
Curr Opin Oncol; 1991 Feb; 3(1):54-62. PubMed ID: 1710506
[TBL] [Abstract][Full Text] [Related]
34. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.
Dearden CE; Else M; Catovsky D
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():21-4. PubMed ID: 21599603
[TBL] [Abstract][Full Text] [Related]
35. [Hairy cell leukemia therapy by cladribine].
Ogura M
Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
[TBL] [Abstract][Full Text] [Related]
36. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
Lichtman SM; Wasil T; Ahmad M; Brody J
Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
Guest JF; Smith H; Sladkevicius E; Jackson G
Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
[TBL] [Abstract][Full Text] [Related]
38. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
[TBL] [Abstract][Full Text] [Related]
39. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
40. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
